Follow the Colgate Palmolive Co stock price and the full directors' dealings record of the company, a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Operating in the Retail & Commerce sector, Colgate Palmolive Co has logged 329 reports. Market capitalisation: €76.1bn. The latest transaction was disclosed on 2 July 2026 (Attribution). Among the most active insiders: BILBREY JOHN P. Every trade is accessible without an account.
Analysts rate Colgate Palmolive Co Buy (bullish), based on 20 analysts. Average price target: US$95.85.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 329 declarations
Colgate-Palmolive Company (ticker: CL) is a large-cap consumer staples company listed in the United States on the NYSE (New York Stock Exchange). For French-, Belgian- and Swiss-based investors, it is best understood as a global defensive franchise in everyday consumer goods, with demand tied to recurring household spending rather than economic cycles. The company traces its roots back to 1806, when William Colgate founded the original business, and over time it evolved through expansion and acquisitions into one of the world’s best-known oral care and personal care groups. Its headquarters are in New York, United States. Colgate-Palmolive’s operations are centered on two main segments: Oral, Personal and Home Care, and Pet Nutrition. The first segment includes oral hygiene, personal care and home care products. Its global brand portfolio includes Colgate, Palmolive, Darlie, elmex, meridol, hello, Protex, Sanex, Softsoap, Speed Stick, Ajax, Fabuloso and Suavitel, among others. The second segment is built around Hill’s Science Diet and Hill’s Prescription Diet, premium pet nutrition brands that provide an attractive source of diversification beyond the company’s historic toothpaste and toothbrush franchise. From a competitive standpoint, Colgate-Palmolive enjoys strong brand equity, broad international reach and a high level of recurring consumption across its categories. In oral care, it is one of the most recognized names globally and has particularly deep penetration in emerging markets. The company sells in more than 200 countries and territories, giving it geographic diversification that is unusually broad for a consumer staples company. Its footprint spans North America, Latin America, Europe, Asia Pacific and Africa/Eurasia. Recent developments in 2025 indicate continued operational execution, with management emphasizing growth, margin discipline, productivity initiatives and ongoing investment in brands and innovation. The company also continues to highlight sustainability and social impact priorities, which remain part of its long-term corporate strategy. For equity investors, CL stands out as a high-quality, cash-generative consumer defensive name with resilient demand characteristics, while still being exposed to foreign exchange movements, competitive pricing pressure and global category dynamics.